188 related articles for article (PubMed ID: 9740670)
41. Translated mutation in the Nurr1 gene as a cause for Parkinson's disease.
Grimes DA; Han F; Panisset M; Racacho L; Xiao F; Zou R; Westaff K; Bulman DE
Mov Disord; 2006 Jul; 21(7):906-9. PubMed ID: 16532445
[TBL] [Abstract][Full Text] [Related]
42. Niemann-Pick C disease: use of denaturing high performance liquid chromatography for the detection of NPC1 and NPC2 genetic variations and impact on management of patients and families.
Millat G; Baïlo N; Molinero S; Rodriguez C; Chikh K; Vanier MT
Mol Genet Metab; 2005; 86(1-2):220-32. PubMed ID: 16126423
[TBL] [Abstract][Full Text] [Related]
43. Molecular analysis using DHPLC of cystic fibrosis: increase of the mutation detection rate among the affected population in Central Italy.
D'Apice MR; Gambardella S; Bengala M; Russo S; Nardone AM; Lucidi V; Sangiuolo F; Novelli G
BMC Med Genet; 2004 Apr; 5():8. PubMed ID: 15084222
[TBL] [Abstract][Full Text] [Related]
44. Efficient detection of factor IX mutations by denaturing high-performance liquid chromatography in Taiwanese hemophilia B patients, and the identification of two novel mutations.
Lin PC; Su YN; Liao YM; Chang TT; Tsai SP; Shu HL; Chiou SS
Kaohsiung J Med Sci; 2014 Apr; 30(4):187-93. PubMed ID: 24656159
[TBL] [Abstract][Full Text] [Related]
45. DHPLC-based germline mutation screening in the analysis of the VHL tumor suppressor gene: usefulness and limitations.
Klein B; Weirich G; Brauch H
Hum Genet; 2001 May; 108(5):376-84. PubMed ID: 11409863
[TBL] [Abstract][Full Text] [Related]
46. NF2 mutation screening by denaturing high-performance liquid chromatography and high-resolution melting analysis.
Sestini R; Provenzano A; Bacci C; Orlando C; Genuardi M; Papi L
Genet Test; 2008 Jun; 12(2):311-8. PubMed ID: 18554169
[TBL] [Abstract][Full Text] [Related]
47. Denaturing high-performance liquid chromatography for mutation detection and genotyping.
Fackenthal DL; Chen PX; Howe T; Das S
Methods Mol Biol; 2013; 1015():25-54. PubMed ID: 23824847
[TBL] [Abstract][Full Text] [Related]
48. Denaturing high-performance liquid chromatography is a suitable method for PMM2 mutation screening in carbohydrate-deficient glycoprotein syndrome type IA patients.
Erlandson A; Stibler H; Kristiansson B; Wahlström J; Martinsson T
Genet Test; 2000; 4(3):293-7. PubMed ID: 11142762
[TBL] [Abstract][Full Text] [Related]
49. Assessment of denaturing high-performance liquid chromatography (DHPLC) in screening for mutations in connexin 26 (GJB2).
Lin D; Goldstein JA; Mhatre AN; Lustig LR; Pfister M; Lalwani AK
Hum Mutat; 2001; 18(1):42-51. PubMed ID: 11438992
[TBL] [Abstract][Full Text] [Related]
50. Complete screening of 50 patients with CHARGE syndrome for anomalies in the CHD7 gene using a denaturing high-performance liquid chromatography-based protocol: new guidelines and a proposal for routine diagnosis.
Bilan F; Legendre M; Charraud V; Manière B; Couet D; Gilbert-Dussardier B; Kitzis A
J Mol Diagn; 2012 Jan; 14(1):46-55. PubMed ID: 22033296
[TBL] [Abstract][Full Text] [Related]
51. Mutational analysis of the human dihydropyrimidine dehydrogenase gene by denaturing high-performance liquid chromatography.
Fischer J; Schwab M; Eichelbaum M; Zanger UM
Genet Test; 2003; 7(2):97-105. PubMed ID: 12885330
[TBL] [Abstract][Full Text] [Related]
52. The sensitivity of denaturing gradient gel electrophoresis: a blinded analysis.
Gejman PV; Cao Q; Guedj F; Sommer S
Mutat Res; 1998 May; 382(3-4):109-14. PubMed ID: 9691991
[TBL] [Abstract][Full Text] [Related]
53. Pitfalls in the denaturing high-performance liquid chromatography analysis of mitochondrial DNA mutation.
Lim KS; Naviaux RK; Wong S; Haas RH
J Mol Diagn; 2008 Jan; 10(1):102-8. PubMed ID: 18165269
[TBL] [Abstract][Full Text] [Related]
54. Denaturing high performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations.
Liu W; Smith DI; Rechtzigel KJ; Thibodeau SN; James CD
Nucleic Acids Res; 1998 Mar; 26(6):1396-400. PubMed ID: 9490783
[TBL] [Abstract][Full Text] [Related]
55. A simple method of investigating mutations in CHEK2 by DHPLC: a study of the German populations of Saxony, Saxony-Anhalt, and Thuringia.
Scharrer U; Skrzypczak-Zielinska M; Wituszynska W; Mierzejewski M; Krause K; Cybulski C; Froster UG
Cancer Genet Cytogenet; 2010 May; 199(1):48-52. PubMed ID: 20417869
[TBL] [Abstract][Full Text] [Related]
56. Denaturing high-performance liquid chromatography (DHPLC) is a highly sensitive, semi-automated method for identifying mutations in the TSC1 gene.
Roberts PS; Jozwiak S; Kwiatkowski DJ; Dabora SL
J Biochem Biophys Methods; 2001 Jan; 47(1-2):33-7. PubMed ID: 11179759
[TBL] [Abstract][Full Text] [Related]
57. DNA mutation detection using denaturing high-performance liquid chromatography (DHPLC).
Yu B; Sawyer NA; Chiu C; Oefner PJ; Underhill PA
Curr Protoc Hum Genet; 2006 Feb; Chapter 7():Unit7.10. PubMed ID: 18428395
[TBL] [Abstract][Full Text] [Related]
58. Rapid, sensitive and inexpensive detection of SCN5A genetic variations by high resolution melting analysis.
Millat G; Chanavat V; Rodriguez-Lafrasse C; Rousson R
Clin Biochem; 2009 Apr; 42(6):491-9. PubMed ID: 19026623
[TBL] [Abstract][Full Text] [Related]
59. Quantitative denaturing high performance liquid chromatography (Q-dHPLC) detection of APC long DNA in faeces from patients with colorectal cancer.
Kalimutho M; Blanco Gdel V; Gravina P; Cretella M; Mannucci L; Mannisi E; Formosa A; Pallone F; Federici G; Bernardini S
Clin Chem Lab Med; 2010 Sep; 48(9):1303-11. PubMed ID: 20504269
[TBL] [Abstract][Full Text] [Related]
60. Denaturing high-performance liquid chromatography for the detection of mutations and polymorphisms in UBE3A.
Bercovich D; Beaudet AL
Genet Test; 2003; 7(3):189-94. PubMed ID: 14641994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
